CompletedNCT05883761
Birth Outcomes In Eswatini After Transition To Dolutegravir-Based Treatment
Studying Neural tube defect
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Elizabeth Glaser Pediatric AIDS Foundation
- Principal Investigator
- Michelle Gill, PhDElizabeth Glaser Pediatric AIDS Foundation
- Enrollment
- 50075 target
- Eligibility
- FEMALE
- Timeline
- 2021 – 2023
Study locations (5)
- Good Shepherd Hospital, Lubombo, Lubombo Region, Eswatini
- Hlathikhulu Hospital, Shiselweni, Shiselweni District, Eswatini
- Mankayane Government Hospital, Manzini, Eswatini
- Raleigh Fitkin Memorial Hospital, Manzini, Eswatini
- Mbabane Government Hospital, Mbabane, Eswatini
Collaborators
Ministry of Health Eswatini · George Washington University
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05883761 on ClinicalTrials.govOther trials for Neural tube defect
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06946563Fetoscopic Neural Tube Defect RepairOregon Health and Science University
- RECRUITINGNANCT05672849Safety and Efficacy of Devices Used in Fetoscopic Neural Tube Defect Repair CasesMichael A Belfort
- ACTIVE NOT RECRUITINGPHASE1NCT03794011Patch vs. No Patch Fetoscopic Meningomyelocele Repair StudyBaylor College of Medicine
- RECRUITINGNANCT03856034Laparotomy Versus Percutaneous Endoscopic Correction of MyelomeningoceleUSFetus
- RECRUITINGNANCT04362592In-Utero Endoscopic Correction of Spina BifidaUniversity of Southern California
- ACTIVE NOT RECRUITINGNANCT03090633Fetoscopic Repair of Isolated Fetal Spina BifidaJohns Hopkins University